Sign Up to like & get
recommendations!
0
Published in 2024 at "Neurology and Therapy"
DOI: 10.1007/s40120-024-00584-y
Abstract: Multiple sclerosis (MS) is a disabling disease with unpredictable clinical manifestations. As clinical assessments may not fully capture the impact of MS on quality of life, they can be complemented by patient-reported outcome (PRO) measures…
read more here.
Keywords:
semi structured;
relapsing remitting;
life;
symptoms impacts ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2020 at "Value in Health"
DOI: 10.1016/j.jval.2020.08.1008
Abstract: Objectives: In this unprecedented era of conducting clinical research during a global pandemic a Patient-Reported Outcomes (PRO) tool is required to (1) provide a comprehensive epidemiological understanding of SARS-COV-2 (COVID-19) symptoms, clustering and resolution;(2) provide…
read more here.
Keywords:
reported outcomes;
signs symptoms;
infection;
symptoms impacts ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2024.2319820
Abstract: Abstract Objective Limited real-world evidence exists to better understand the patient experience of living with symptoms and impacts of non-alcoholic steatohepatitis (NASH). This study aimed to (1) describe patient-reported perspectives of NASH symptoms and impacts…
read more here.
Keywords:
treatment;
nash symptoms;
real world;
symptoms impacts ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-055989
Abstract: Objectives There is little in-depth qualitative evidence of how symptoms manifest themselves in outpatients with COVID-19 and how these in turn impact outpatients’ daily lives. The objective of the study was therefore to explore the…
read more here.
Keywords:
patient experience;
symptoms impacts;
impacts covid;
daily life ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Orphanet Journal of Rare Diseases"
DOI: 10.1186/s13023-025-03654-y
Abstract: Gaucher disease type 3 (GD3) is a lysosomal storage disease characterized by diverse neurological and systemic manifestations. Symptoms of ataxia, cognitive impairment, and other systemic symptoms profoundly impact daily activities and the quality of life…
read more here.
Keywords:
disease;
ataxia cognitive;
signs symptoms;
conceptual model ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of Parkinson's disease"
DOI: 10.3233/jpd-225068
Abstract: BACKGROUND Patient perspectives on meaningful symptoms and impacts in early Parkinson's disease (PD) are lacking and are urgently needed to clarify priority areas for monitoring, management, and new therapies. OBJECTIVE To examine experiences of people…
read more here.
Keywords:
symptoms impacts;
early stage;
disease;
parkinson disease ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Journal of Parkinson's disease"
DOI: 10.3233/jpd-225122
Abstract: BACKGROUND Adoption of new digital measures for clinical trials and practice has been hindered by lack of actionable qualitative data demonstrating relevance of these metrics to people with Parkinson's disease. OBJECTIVE This study evaluated of…
read more here.
Keywords:
relevance;
symptoms impacts;
digital measures;
parkinson disease ... See more keywords